Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Phathom Pharmaceuticals, Inc. (PHAT)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Phathom Pharmaceuticals, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Phathom Pharmaceuticals, Inc. since 2005.
The reporting company's ticker symbol is PHAT. The reporting company's CIK number is 1783183.
The total value of stock buying since 2005 is $39,999,978.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-10-29||Edwards Jonathan S. (Director)||Buy||1,052,631||19.00||19,999,989|
|2019-10-29||Fhmls Ix, L.p. (10% Owner)||Buy||1,052,631||19.00||19,999,989|
Insider trading activities including stock purchases, stock sales, and option exercises of PHAT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Phathom Pharmaceuticals, Inc. (symbol PHAT, CIK number 1783183) see the Securities and Exchange Commission (SEC) website.